Credit Suisse Group (NYSE:CS) was downgraded by Zacks Investment Research from a "buy" rating to a "hold" rating in a research note issued on Friday, Zacks.com reports.
According to Zacks, "CREDIT SUISSE GROUP and Winterthur offer investment products, private banking and financial advisory services, as well as insurance and pension solutions. Credit Suisse First Boston provides securities underwriting, sales and trading, financial advisory, investment research, venture capital and asset management services. Because they specialize in gaining a deep understanding of their clients' financial needs, they know that no one's needs are two-dimensional. 360° Choice. "
A number of other research firms have also recently issued reports on CS. UBS Group reaffirmed a "neutral" rating on shares of Credit Suisse Group in a report on Wednesday, December 2nd. Morgan Stanley reaffirmed an "overweight" rating on shares of Credit Suisse Group in a research report on Friday, October 30th. JPMorgan Chase & Co. reissued an "overweight" rating on shares of Credit Suisse Group in a report on Tuesday. Deutsche Bank Aktiengesellschaft reissued a "buy" rating on shares of Credit Suisse Group in a research report on Monday, December 7th. Finally, Royal Bank of Canada reaffirmed a "sector perform" rating on shares of Credit Suisse Group in a research report on Wednesday, December 16th. Six investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. Credit Suisse Group has a consensus rating of "Buy" and a consensus price target of $12.25.
Shares of Credit Suisse Group stock traded down $0.09 during midday trading on Friday, hitting $14.45. The company had a trading volume of 3,849,915 shares, compared to its average volume of 2,149,185. The stock has a market cap of $36.24 billion, a price-to-earnings ratio of 9.09, a PEG ratio of 0.66 and a beta of 1.60. Credit Suisse Group has a 12-month low of $6.47 and a 12-month high of $14.95. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 3.57. The company has a fifty day simple moving average of $13.77 and a 200 day simple moving average of $11.96.
A number of hedge funds and other institutional investors have recently made changes to their positions in CS. CAPROCK Group Inc. grew its position in shares of Credit Suisse Group by 8.1% in the fourth quarter. CAPROCK Group Inc. now owns 10,830 shares of the financial services provider's stock valued at $139,000 after purchasing an additional 810 shares in the last quarter. Signaturefd LLC raised its holdings in shares of Credit Suisse Group by 4.3% during the 4th quarter. Signaturefd LLC now owns 24,777 shares of the financial services provider's stock worth $317,000 after acquiring an additional 1,029 shares during the period. Rhumbline Advisers boosted its position in shares of Credit Suisse Group by 10.4% during the 4th quarter. Rhumbline Advisers now owns 11,317 shares of the financial services provider's stock valued at $145,000 after acquiring an additional 1,070 shares during the last quarter. Greenleaf Trust grew its holdings in shares of Credit Suisse Group by 8.3% in the third quarter. Greenleaf Trust now owns 15,203 shares of the financial services provider's stock valued at $152,000 after purchasing an additional 1,169 shares during the period. Finally, Advisor Partners LLC increased its position in Credit Suisse Group by 7.7% during the third quarter. Advisor Partners LLC now owns 16,714 shares of the financial services provider's stock worth $167,000 after purchasing an additional 1,200 shares during the last quarter. 2.07% of the stock is owned by institutional investors.
Credit Suisse Group Company Profile
Credit Suisse Group AG, through its subsidiaries, provides various financial services in Switzerland, Europe, the Middle East, Africa, the Americas, and Asia Pacific. The company offers private banking and wealth management solutions, including advisory, investment, financial planning, succession planning, and trust services; and financing and lending, and multi-shore platform solutions.
Featured Story: Arbitrage
Get a free copy of the Zacks research report on Credit Suisse Group (CS)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]
15 Healthcare Stocks that Analysts Love
There are more than 200 healthcare companies traded on public markets. Given the sheer number of pharmaceutical companies, medical research firms, hospital systems, and other healthcare stocks, it can be hard to identify which healthcare companies will outperform the market.
Fortunately, Wall Street's brightest minds have already done this for us. Every year, analysts issue approximately 3,000 distinct recommendations for healthcare companies. Analysts don't always get their "buy" ratings right, but it's worth taking a hard look when several analysts from different brokerages and research firms are giving "strong-buy" and "buy" ratings to the same healthcare stock.
This slide show lists the 15 healthcare companies with the highest average analyst recommendations from Wall Street's equities research analysts over the last 12 months.
View the "15 Healthcare Stocks that Analysts Love".